Make more informed decisions from factual data, enriched with the sentiment and opinion of patients, clinicians, payers & investors.
The challenge: Evaluating assets and companies requires significant internal capability and external consulting can slow you down when you need to make decisions quickly.
The solution: Our technology driven approach draws upon our full range of tools to provide you with the evidence you need to make your decision and reach a valuation, faster than your competition.
- Clinical and competitive landscape assessments
- Epidemiology across your target markets
- Physician, patient and investor perspectives on disease, technology, product and company
- We can address specific questions such as safety concerns and competing technologies
- Prioritisation of indications
- Pricing assumptions for orphan or new assets in an established market